Maxim Group initiated coverage on shares of Health In Tech (NASDAQ:HIT – Free Report) in a research note released on Thursday,Benzinga reports. The brokerage issued a buy rating and a $2.50 price target on the stock.
Separately, Wall Street Zen downgraded Health In Tech from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 7th.
View Our Latest Stock Analysis on Health In Tech
Health In Tech Stock Up 5.3%
Health In Tech (NASDAQ:HIT – Get Free Report) last announced its quarterly earnings results on Monday, April 14th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The firm had revenue of $8.02 million for the quarter, compared to the consensus estimate of $6.87 million.
Hedge Funds Weigh In On Health In Tech
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Jane Street Group LLC acquired a new stake in Health In Tech in the first quarter valued at $48,000. Arete Wealth Advisors LLC bought a new stake in shares of Health In Tech in the 1st quarter valued at about $47,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Health In Tech in the first quarter valued at about $41,000. Finally, XTX Topco Ltd acquired a new stake in shares of Health In Tech in the first quarter valued at about $59,000.
About Health In Tech
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Recommended Stories
- Five stocks we like better than Health In Tech
- Trading Stocks: RSI and Why it’s Useful
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- Dividend Capture Strategy: What You Need to Know
- Is IBM’s AI Transformation Powering a Sustained Rally?
- NYSE Stocks Give Investors a Variety of Quality Options
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.